Insider Stock Trading History of Narine Jeenarine


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Narine Jeenarine since year 2005. The trader's CIK number is 1465822. At the time of this reporting, Narine Jeenarine is the Director of Elite Pharmaceuticals Inc /de/ . (stock ticker symbol ELI). See this page for all insider trading activities at Elite Pharmaceuticals Inc /de/ .


Stock purchases, sales, and option exercises reported by insider Narine Jeenarine since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-05-09 ELTP Elite Pharmaceuticals Inc /de/ Sale 329,437 .38 125,844
2014-04-02 ELTP Elite Pharmaceuticals Inc /de/ Sale 147,664 .41 60,542
2014-03-27 ELTP Elite Pharmaceuticals Inc /de/ Sale 190,172 .43 81,203
2014-03-11 ELTP Elite Pharmaceuticals Inc /de/ Sale 239,367 .60 144,098
2014-03-06 ELTP Elite Pharmaceuticals Inc /de/ Sale 773,050 .90 692,652
2014-03-07 ELTP Elite Pharmaceuticals Inc /de/ Sale 1,051,450 .68 714,986
2014-01-13 ELTP Elite Pharmaceuticals Inc /de/ Sale 805,583 .18 147,421
2013-01-03 ELTP Elite Pharmaceuticals Inc /de/ Sale 531,185 .15 79,677
2013-12-05 ELTP Elite Pharmaceuticals Inc /de/ Sale 275,000 .13 34,650
2013-11-26 ELTP Elite Pharmaceuticals Inc /de/ Sale 23,626 .12 2,787
2013-11-11 ELTP Elite Pharmaceuticals Inc /de/ Sale 39,000 .12 4,797
2013-11-26 ELTP Elite Pharmaceuticals Inc /de/ Sale 357,000 .12 43,197
2013-11-27 ELTP Elite Pharmaceuticals Inc /de/ Sale 25,000 .12 3,025
2013-11-19 ELTP Elite Pharmaceuticals Inc /de/ Sale 21,000 .12 2,499
2013-11-14 ELTP Elite Pharmaceuticals Inc /de/ Sale 465,090 .12 53,485
2013-11-15 ELTP Elite Pharmaceuticals Inc /de/ Sale 318,050 .12 37,211
2013-11-18 ELTP Elite Pharmaceuticals Inc /de/ Sale 1,170,000 .12 138,060
2013-11-06 ELTP Elite Pharmaceuticals Inc /de/ Sale 122,200 .12 15,152
2013-10-28 ELTP Elite Pharmaceuticals Inc /de/ Sale 102,300 .13 13,299
2013-10-29 ELTP Elite Pharmaceuticals Inc /de/ Sale 102,520 .01 1,332
2013-01-22 ELTP Elite Pharmaceuticals Inc /de/ Sale 356,700 .09 32,103
2013-01-14 ELTP Elite Pharmaceuticals Inc /de/ Option Ex 6,032,000 .06 380,016
2013-01-11 ELTP Elite Pharmaceuticals Inc /de/ Sale 2,339,000 .09 212,849
2012-12-26 ELTP Elite Pharmaceuticals Inc /de/ Sale 561,000 .09 51,051
2012-12-19 ELTP Elite Pharmaceuticals Inc /de/ Sale 243,300 .09 22,383
2012-03-26 ELTP Elite Pharmaceuticals Inc /de/ Sale 225,000 .10 21,375
2012-03-27 ELTP Elite Pharmaceuticals Inc /de/ Sale 735,000 .09 66,150
2012-03-23 ELTP Elite Pharmaceuticals Inc /de/ Sale 1,765,000 .10 169,440
2012-03-16 ELTP Elite Pharmaceuticals Inc /de/ Sale 85,000 .10 8,585
2011-02-03 ELTP Elite Pharmaceuticals Inc /de/ Buy 407,949 .04 16,317

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Narine Jeenarine (Director of Elite Pharmaceuticals Inc /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.